Hyongbum Henry Kim

Title: Innovations of Hyongbum Henry Kim in Genome Editing

Introduction

Hyongbum Henry Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genome editing, particularly in addressing genetic disorders. His innovative work has led to the development of a unique composition aimed at correcting specific genetic mutations.

Latest Patents

Hyongbum Henry Kim holds a patent for a composition for prime editing that includes pegRNA for editing mutations associated with alpha-1 antitrypsin deficiency. This groundbreaking patent provides a genome editing composition that incorporates a prime editor protein and a prime editing guide RNA. The composition is designed to effectively edit a Z-type mutation of the SERPINA1 gene, which is crucial for treating alpha-1 antitrypsin deficiency. The pegRNA sequence included in the composition allows for high accuracy in genome editing, making it a valuable tool for potential therapeutic applications.

Career Highlights

Hyongbum Henry Kim is affiliated with Yonsei University, where he conducts research and develops innovative solutions in the field of genetic engineering. His work has garnered attention for its potential to improve treatment options for genetic disorders.

Collaborations

He collaborates with notable colleagues, including Minyoung Lee and Yoo Jin Chang, who contribute to his research endeavors and help advance the field of genome editing.

Conclusion

Hyongbum Henry Kim's contributions to genome editing represent a significant advancement in the treatment of genetic disorders. His innovative patent and collaborative efforts highlight the importance of research in developing effective therapies for conditions like alpha-1 antitrypsin deficiency.